纵横研报
Ticker Detail

TLIS.US

Talis Biomedical Corp Medical Devices
00Reports USA 医疗健康
医疗健康 · 医疗器械

Talis Biomedical Corporation does not have significant operations. Previously, it was involved in the development of medical devices for infectious diseases and other conditions at the point of care in the United States. The company evaluates strategic alternatives, including acquisition, merger, reverse merger, divestiture of assets, a voluntary reorganization, dissolution or liquidation, and licensing or other strategic transactions. Talis Biomedical Corporation was incorporated in 2013 and is based in Chicago, Illinois.

MARKET 市值 5M USD 52W $1.15 – $2.84 EODHD · Q 2024-06-30 · 同步 2026-07-12
QUALITY PEG 营收 YoY -94.0% ROE -70.5% 营业利润率 -11360.3% 净利润率 0.0%
ANALYST 一致评级 1.00 一致目标价 $5

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制